Asia in counterfeits chase; disposables penetrate high-potency API-making;

> Korea has seen a 23-fold rise in counterfeit impotence drugs over the past five years, with the majority coming from China. Article

> China's State Food and Drug Administration has provided the names of 33 fake drugs to help provincial and national authorities investigate counterfeiting. Article

> In five to ten years, disposable components may account for more than 90 percent of equipment used to make highly potent APIs. Article

> Shire will remove low-blood pressure drug ProAmatine from the market, rather than conduct the additional clinical trials the FDA has requested. Article

> Cannabis Science has licensed Denver-based RockBrook to manufacture and sell its medical marijuana formulations and delivery systems. Release

Special Report: The top counterfeit drugs. Read >>

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.